Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Coly Inc. (4175:JPX), powered by AI.
Coly Inc. is currently trading at ¥1,946. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Coly Inc. on Alpha Lenz.
View Coly Inc.'s valuation metrics on Alpha Lenz.
“Coly Inc.'s ROE is 1.4%. Explore profitability and growth together.”
Ask for details →Coly Inc. operates as a technology-driven company involved in the development and advancement of digital solutions with a focus on healthcare and medical sectors. Its primary function is to deliver innovative platforms and services that enhance healthcare efficiency and patient engagement. Notable features of Coly's operations include the integration of artificial intelligence and machine learning to streamline medical data processing, thereby providing healthcare professionals with actionable insights and facilitating improved patient care outcomes. Coly's solutions are pivotal in the digital transformation of healthcare institutions, thus impacting a broad range of industries including biotech, pharmaceuticals, and clinical management systems. This company's presence in the market highlights the growing demand for technological innovations to address complex healthcare challenges, emphasizing its role as a key player in the intersection of technology and healthcare service delivery.
“Coly Inc.'s ROE is 1.4%. Explore profitability and growth together.”
Ask for details →Coly Inc. (ticker: 4175) is a company listed on JPX in the Communication Services sector (Electronic Gaming & Multimedia). It has approximately 269 employees.
The current price is 1,946 with a P/E ratio of -x and P/B of -x.
ROE is 1.36% and operating margin is -2.05%. Annual revenue is $7.0B.